Article body
Lipids are important mediators in cancer and inflammation, and in cardiovascular, neurodegenerative and metabolic diseases. A complex protein�lipid signalling network that comprises phosphoinositides, sphingolipids, steroids and other lipid-derived mediators has been uncovered in recent years.
This Poster provides an overview of the protein�lipid signalling network and how this network can be exploited to attenuate proliferative, inflammatory and metabolic diseases, and accompanies a review article by Matthias P. Wymann and Roger Schneiter in the February 2008 issue, which contains a Focus on Lipids.
The Poster is freely available thanks to support from Merck Serono International S.A.
